Literature DB >> 22854727

Early mortality and years of potential life lost among Veterans Affairs patients with depression.

Kara Zivin1, Mark A Ilgen, Paul Nelson Pfeiffer, Deborah E Welsh, John McCarthy, Marcia Valenstein, Erin M Miller, Khairul Islam, Helen C Kales.   

Abstract

OBJECTIVE: Substantial literature documents excess and early mortality among individuals with serious mental illness, but there are relatively few data about mortality and depression.
METHODS: During fiscal year 2007, data from the U.S. Department of Veterans Affairs and the National Death Index were used to calculate mean age of death and years of potential life lost (YPLL) associated with 13 causes of death among veterans with (N=701,659) or without (N=4,245,193) depression.
RESULTS: Compared with nondepressed patients, depressed patients died younger (71.1 versus 75.9) and had more YPLL (13.4 versus 10.2) as a result of both natural and unnatural causes. Depending on the cause of death, depressed patients died between 2.5 and 8.7 years earlier and had 1.5 to 6.1 YPLL compared with nondepressed patients.
CONCLUSIONS: These findings have important implications for clinical practice, given that improved quality of care may be needed to reduce early mortality among depressed VA patients.

Entities:  

Mesh:

Year:  2012        PMID: 22854727     DOI: 10.1176/appi.ps.201100317

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  9 in total

1.  Depression and telomere length: A meta-analysis.

Authors:  Kathryn K Ridout; Samuel J Ridout; Lawrence H Price; Srijan Sen; Audrey R Tyrka
Journal:  J Affect Disord       Date:  2015-12-02       Impact factor: 4.839

2.  Antidepressant Medication Treatment and Risk of Death.

Authors:  Kara Zivin; H Myra Kim; Matheos Yosef; Donovan T Maust; Marcia Valenstein; Eric G Smith; Dimitry S Davydow
Journal:  J Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.153

3.  What Should be Done When Elderly Patients with Major Depression Have Failed to Respond to All Treatments?

Authors:  Carlos A Zarate
Journal:  Am J Geriatr Psychiatry       Date:  2017-08-30       Impact factor: 4.105

4.  Perceived Discrimination in Health Care and Mental Health/Substance Abuse Treatment Among Blacks, Latinos, and Whites.

Authors:  Vickie M Mays; Audrey L Jones; Ayesha Delany-Brumsey; Courtney Coles; Susan D Cochran
Journal:  Med Care       Date:  2017-02       Impact factor: 2.983

5.  Physical activity in depressed elderly. A systematic review.

Authors:  Gioia Mura; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2013-07-12

Review 6.  Social determinants of depression and suicidal behaviour in the Caribbean: a systematic review.

Authors:  Catherine R Brown; Ian R Hambleton; Natasha Sobers-Grannum; Shawn M Hercules; Nigel Unwin; E Nigel Harris; Rainford Wilks; Marlene MacLeish; Louis Sullivan; Madhuvanti M Murphy
Journal:  BMC Public Health       Date:  2017-06-15       Impact factor: 3.295

7.  Enhanced care planning and clinical-community linkages versus usual care to address basic needs of patients with multiple chronic conditions: a clinician-level randomized controlled trial.

Authors:  Alex H Krist; Kristen O'Loughlin; Steven H Woolf; Roy T Sabo; Jennifer Hinesley; Anton J Kuzel; Bruce D Rybarczyk; Paulette Lail Kashiri; E Marshall Brooks; Russel E Glasgow; Amy G Huebschmann; Winston R Liaw
Journal:  Trials       Date:  2020-06-11       Impact factor: 2.279

8.  Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings.

Authors:  Alejandra Maciel; Ali Cullors; Andrew A Lukowiak; Jorge Garces
Journal:  Neuropsychiatr Dis Treat       Date:  2018-01-08       Impact factor: 2.570

9.  Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis.

Authors:  Jeffrey Voigt; Linda Carpenter; Andrew Leuchter
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.